Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Park Inn by Radisson Amsterdam City West

Nov 17, 2026 8:30 AM - Nov 19, 2026 4:30 PM

La Guardiaweg 59, 1043 DE Amsterdam, Netherlands

20th Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

Early-Bird for DIA Industry Members

DAYS

HOURS

MINUTES

SECONDS

Overview

The 20th DIA Global Forum for Qualified Persons for Pharmacovigilance (QPPV) is a long-standing international meeting designed by QPPVs for QPPVs, providing a trusted platform for discussion of current challenges, regulatory expectations, and best practices shaping the QPPV role.

 

Participants can expect valuable insights, peer-to-peer discussion, and opportunities to connect with experts from across the pharmacovigilance community.

 

The Programme Committee is currently working to develop an exciting and forward-looking programme for this milestone edition. Further details, including confirmed topics and speakers, will be announced soon.

 

 


Participant Testimonials

Love the general feel of the meeting - friendly, open, honest and all willing to share and learn.

I heard a lot of valuable input for topics under discussion in my company.

A great gathering of experts discussing relevant topics.

One of the best QPPV forums in a while. Really relevant and realistic discussions with like-minded individuals.

Who should attend?

  • QPPVs and Deputies from any territory
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/ Leaders
  • Auditors
  • Medical and Regulatory Affairs Experts
  • Aspiring PV Specialists/QPPVs
  • QPPV Support Staff

Short Course or Primer

To keep you at the forefront.

Nov 17, 2026

Globalisation of the Pharmacovigilance System Master File (PSMF):

Nov 17, 2026

QPPV Oversight, Governance and Accountability:

Program Committee

  • Claire  Longman, MSc
    Claire Longman, MSc Expert Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Shahinaz  Badr, PharmD
    Shahinaz Badr, PharmD Founder & Managing Director
    Vigilance Gate FZ,LLC, United Arab Emirates
  • Ilaria  Grisoni, MSc
    Ilaria Grisoni, MSc Executive Director, Head of International QPPV Office, EEA QPPV
    Jazz Pharmaceuticals, Italy
  • Birgit  Van De Vliet
    Birgit Van De Vliet Senior Director Global Safety, EU Deputy QPPV
    GSK, Belgium
  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director PV, Managing partner
    DADA Consultancy B.V., Netherlands
  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Senior Director, Deputy EU QPPV
    AstraZeneca, Spain
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director Europe | International - Patient Safety
    Bristol Myers Squibb, Switzerland
  • Birgit  Van de Vliet
    Birgit Van de Vliet Global Sr Director Safety Governance and Deputy EU QPPV process
    GSK, Belgium
  • Sina  Schader, DrMed
    Sina Schader, DrMed Head of QPPV Office and EU QPPV
    AbbVie, Germany

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.